AFP and hepatocellular carcinoma: A comparison between miRNA-424 and AFP (the current HCC serum biomarker) resulted in comparable sensitivities, 63.46% for the former and 62.32% for the latter, although AFP specificity and accuracy (64.57% and 63.78%) were better than those for miR-424 (57.9% and 59.86%).